Author

Monica Coenraads

Rett Syndrome Research Trust

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Amy E. Clipperton‐Allen· 1 shared Anastasia KhvorovaiD· 1 shared Ashley SummersiD· 1 shared Chantal Ferguson· 1 shared Daniel O’ReillyiD· 1 shared David CooperiD· 1 shared Dimas EcheverriaiD· 1 shared Hassan H. FakihiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Amy E. Clipperton‐Allen

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Single-dose administration of therapeutic divalent siRNA targeting MECP2 prevents lethality for one year in an MECP2 duplication mouse model

Vignesh Narayan Hariharan, Ashley Summers, Amy E. Clipperton‐Allen, Jillian Caiazzi, Samuel R. Hildebrand, Daniel O’Reilly, Qi Tang, Zachary Kennedy, Dimas Echeverria, Nicholas McHugh, David Cooper, Jacquelyn Sousa, Chantal Ferguson, Hassan H. Fakih, Laurent P. Bogdanik, , Anastasia Khvorova

Therapeutic siRNAs provide safe and durable modulation of MECP2 for the treatment of mild and severe MECP2 Duplication Syndrome.

Nature Communications · Jul 21, 2026Peer-reviewedNeuroscience